See also this year's filing and all EDGAR filings for this company.
PDF Report 0001807120_2022_Design_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001807120')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001807120, Design Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 385,435,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,508,000 |
| 3 | remainder_Assets | 3,614,000 |
| 4 | LiabilitiesCurrent | 5,283,000 |
| 5 | LiabilitiesNoncurrent | 3,144,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,053,000 |
| 9 | ResearchAndDevelopmentExpense | 24,778,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 298,000 |
| 13 | remainder_ComprehensiveNetIncome | -400,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 390,557,000 |
| 1 | Liabilities | 8,427,000 |
| 2 | Expenses | 35,831,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 382,130,000 |
| 5 | NetIncome | -35,533,000 |
| 6 | ComprehensiveNetIncome | -35,733,000 |
| 7 | BaseVar | 217,756,500 |
| 8 | EconomicCapitalRatio | 3.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
